Article
Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo.
Oncotarget - 22 Nov 2016
Jung Chae Lim, Mun Hyemin, Jo Se-Young, Oh Ju-Hee, Lee ChuHee, Choi Eun-Kyung, Jang Se Jin, Suh Young-Ah
Abstract excerpt
Mutation of p53 occasionally results in a gain of function, which promotes tumor growth. We asked whether destabilizing the gain-of-function protein would kill tumor cells. Downregulation of the gene reduced cell proliferation in p53-mutant cells, but not in p53-null cells, indicating that the former depended on the mutant protein for survival. Moreover, phenformin and 2-deoxyglucose suppressed cell growth and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
